137 related articles for article (PubMed ID: 6308993)
1. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors.
DeLaPaz RL; Patronas NJ; Brooks RA; Smith BH; Kornblith PL; Milam H; Di Chiro G
AJNR Am J Neuroradiol; 1983; 4(3):826-9. PubMed ID: 6308993
[TBL] [Abstract][Full Text] [Related]
2. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S
J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of brain tumors using positron emission tomography].
Schober O; Meyer GJ
Radiologe; 1992 Jun; 32(6):282-9. PubMed ID: 1322547
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
6. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Pirotte B; Goldman S; Bidaut LM; Luxen A; Stanus E; Brucher JM; Balériaux D; Brotchi J; Levivier M
Acta Neurochir (Wien); 1995; 134(1-2):79-82. PubMed ID: 7668134
[TBL] [Abstract][Full Text] [Related]
7. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
8. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
9. Prediction of survival in glioma patients by means of positron emission tomography.
Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
[TBL] [Abstract][Full Text] [Related]
10. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors.
Schifter T; Hoffman JM; Hanson MW; Boyko OB; Beam C; Paine S; Schold SC; Burger PC; Coleman RE
J Comput Assist Tomogr; 1993; 17(4):509-61. PubMed ID: 8392523
[TBL] [Abstract][Full Text] [Related]
11. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography-guided stereotactic brain biopsy.
Levivier M; Goldman S; Bidaut LM; Luxen A; Stanus E; Przedborski S; Balériaux D; Hildebrand J; Brotchi J
Neurosurgery; 1992 Oct; 31(4):792-7; discussion 797. PubMed ID: 1407471
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
14. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
15. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
16. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD
Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
20. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
